This week, RestorEar received news that our study, “Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss”, has received funding from the National Institute on Deafness and Other Communication Disorders (NIDCD) for a second year. This clinical trial, which is currently finishing its first year, is investigating the use of mild therapeutic hypothermia delivered by ReBound for the preservation of sensory structures in the inner ear after noise exposure. Check out the clinicaltrials.gov page here.

Using ReBound, our research partners at the University of Miami are testing the safety and efficacy of mild therapeutic hypothermia treatment in mitigating noise-induced hearing loss in firefighters. We are in the process of enrolling up to 116 firefighters serving the South Florida Fire Services as well as non-firefighter controls to undergo hypothermia treatment after routine occupational noise exposure. Subjective and functional assessments of hearing function repeated over time continue to be performed to evaluate the protective effects of mild therapeutic hypothermia following noise exposure. More details about the study can be found here.

To date, we are actively enrolling and testing participants as part of the study. The continued funding from NIDCD will allow us to continue testing participants and bring us one step to FDA approval from ReBound.

For more research updates, visit our Clinical Page and subscribe to our newsletter.